Contemporary approach to antianginal therapy in patients with stable are reviewed. Benefits and limitations of "standard" antiischemic therapy and evidence-based data about alternative therapy with nicorandil are discussed in details.
View Article and Find Full Text PDFAim: To analyse retrospectively quality of medical correction of modified risk factors (RF) and treatment of cardiovascular diseases (CVD) in patients with diabetes mellitus type (DM) 2 admitted to specialized endocrinological departments.
Material And Methods: Analysis of medication policy of CVD RF was made retrospectively for 250 patients treated in endocrinological departments of Moscow hospital in 2003.
Results: Arterial hypertension, coronary heart disease were diagnosed in 93.